tm logo
AUCATZYL
Live/Registered
REGISTERED

on 09 Jul 2024

Last Applicant/ Owned by

191 Wood Lane LondonW12 7FP

GB

Serial Number

79370753 filed on 27th Apr 2023

Registration Number

7435621 registered on 09th Jul 2024

in the Principal Register

Correspondent Address

Rebecca Liebowitz

Rebecca Liebowitz Venable LLP

Washington, DC 20043-9998

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

AUCATZYL

Medical and veterinary preparations for therapeutic purposes for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; medical preparations for cell therapy for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; medical preparations for gene therapy for the treatment of Read More

Classification Information


Class [005]
Pharmaceutical Products


Medical and veterinary preparations for therapeutic purposes for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; medical preparations for cell therapy for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; medical preparations for gene therapy for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; medical preparations for cancer therapies for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; cells for medical or clinical use, namely cells featuring chimeric antigen receptors (CAR) and therapeutic preparations thereof for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; antibodies for medical purposes for the treatment of cancer, genetic conditions, immune response disorders, autoimmune diseases and infectious diseases; preparations for genetically modifying human or animal cells for medical purposes, including viral vectors, namely, culture media for cultivating and augmentation of human and animal cells; preparations of blood extracted from humans or animals which have been adapted for therapeutic purposes; pharmaceutical preparations for use in the treatment of cancer; biological preparations for the treatment of cancer; pharmaceutical and biological preparations for immunotherapy, including T cell therapy; vaccines


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79370753

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 60895-591404

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
09th Oct 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09th Jul 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
09th Jul 2024REGISTERED-PRINCIPAL REGISTER
30th Apr 2024NOTIFICATION PROCESSED BY IB
23rd Apr 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23rd Apr 2024PUBLISHED FOR OPPOSITION
10th Apr 2024NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
10th Apr 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
03rd Apr 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
16th Mar 2024APPROVED FOR PUB - PRINCIPAL REGISTER